AKT1 and glioblastoma: However, for patients with relatively high expression of NTN4 and ITGB4 in glioblastoma tumors, the prevention of NTN4/ITGB4 interaction or concomitant use of the inhibitors of the AKT pathway may improve the therapeutic benefit of temozolomide.